Bioarchitech is developing a treatment to enable the body’s own immune system to kill cancer cells. To do this, the team is engineering a virus (a strain of the smallpox vaccine) with unique genes that will encode antibody-like immunotherapy molecules to stimulate an immune response to cancer cells.
